ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia ; volume:14 ; number:1 ; day:19 ; month:9 ; year:2023 ; pages:1-16 ; date:12.2023
Nature Communications ; 14, Heft 1 (19.9.2023), 1-16, 12.2023
- Urheber
-
Ebner, Jessica
Schmoellerl, Johannes
Piontek, Martin
Manhart, Gabriele
Troester, Selina
Carter, Bing Z.
Neubauer, Heidi
Moriggl, Richard
Szakács, Gergely
Zuber, Johannes Ekkehart
Köcher, Thomas
Andreeff, Michael
Sperr, Wolfgang Reinhard
Valent, Peter
Grebien, Florian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-41229-2
- URN
-
urn:nbn:de:101:1-2024020210182514328836
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.10.2022, 08:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ebner, Jessica
- Schmoellerl, Johannes
- Piontek, Martin
- Manhart, Gabriele
- Troester, Selina
- Carter, Bing Z.
- Neubauer, Heidi
- Moriggl, Richard
- Szakács, Gergely
- Zuber, Johannes Ekkehart
- Köcher, Thomas
- Andreeff, Michael
- Sperr, Wolfgang Reinhard
- Valent, Peter
- Grebien, Florian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Emerging role of glutathione peroxidase 4 in myeloid cell lineage development and acute myeloid leukemia
Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia
Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK
Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy
Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia
Emerging role of glutathione peroxidase 4 in myeloid cell lineage development and acute myeloid leukemia
Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia
Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK
Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy
Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia
Emerging role of glutathione peroxidase 4 in myeloid cell lineage development and acute myeloid leukemia
Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia
Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK
Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy
Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Immunogenicity of leukemia stem cells in acute myeloid leukemia